A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells Article (Web of Science)

cited authors

  • Peery, Robert; Cui, Qingbin; Kyei-Baffour, Kwaku; Josephraj, Sophia; Huang, Caoqinglong; Dong, Zizheng; Dai, Mingji; Zhang, Jian-Ting; Liu, Jing-Yuan

authors

publication date

  • July 1, 2022

webpage

published in

category

keywords

  • Docetaxel
  • Prostate cancer
  • Protein-Protein Interaction
  • Small-molecule inhibitor
  • Survivin

volume

  • 65